(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Consolidated Research: 2018 Summary Expectations for SandRidge Energy, BIOVERATIV INC, Ultra Clean, The Mosaic, Papa John's International, and Chegg — Fundamental Analysis, Key Performance Indications

March 06, 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SandRidge Energy, Inc....

IPG Photonics Set to Join S&P 500; ALLETE and LendingTree to Join S&P MidCap 400; New York Mortgage Trust, Global Net Lease and Finisar to Join S&P SmallCap 600

March 02, 2018

S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600:

Performance

More News

Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ

February 22, 2018

Bioverativ Announces First Patient Dosed in Phase 3 Study of BIVV009 for Treatment of Cold Agglutinin Disease

March 05, 2018

What Does A Double Bottom Base Look Like? This Top Biotech Stock Formed A Great One

March 01, 2018

Why 2018 Could Be An 'Explosive' Year For Biotech Mergers

February 16, 2018

BRIEF-Sanofi Completes Acquisition Of Bioverativ Inc.

March 08, 2018

Haemophilia Publishes a Retrospective Analysis Investigating the Use of ELOCTATE® for Immune Tolerance Induction in People with Inhibitors and Severe Hemophilia A

February 13, 2018

Bioverativ Reports Fourth Quarter and Full Year 2017 Performance

February 13, 2018

SPMD, NKTR, ABMD, BIVV: ETF Outflow Alert

February 22, 2018

Biotech ETFs Head to Head: XBI vs. IBB

March 01, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.